News
NEW! Publication on highly varying concepts and capacities of forensic mental health services across the European Union
We are pleased to announce that an article by the EU-VIORMED group has been published in Frontiers in Public Health on January, 2023. There is wide variation in the processes, structures and treatment models for dealing with mentally disordered offenders across the European Union. There is a serious lack of data on population levels of […]... Read more
NEW! Publication on comparing forensic and non-forensic women with schizophrenia spectrum disorders
We are pleased to announce that an article by the EU-VIORMED group has been published in International Review of Psychiatry on November, 2024. Studies about violence by women with severe mental disorders are rare. The aim of this paper is to analyse the sample of women diagnosed with Schizophrenia Spectrum Disorders (SSD) from the EU-VIORMED […]... Read more
NEW! Publication on The predictive validity and temporal characteristics of the HCR-20v3 for inpatient violence in forensic inpatient settings
We are pleased to announce that an article by the EU-VIORMED group has been published in Psychiatric Research on September, 2024. Aggression and violence are common day to day problems in psychiatric settings. However, the optimal means of assessing that risk remains unclear. In the context of that uncertainty many tools have evolved, among which […]... Read more
NEW! Publication on RISK aversion in Italian forensic and non-forensic patients with schizophrenia spectrum disorders
We are pleased to announce that an article by the EU-VIORMED group has been published in Plos One on July, 2023. Goal-directed decision-making is a central component of the broader reward and motivation system, and requires the ability to dynamically integrate both positive and negative feedback from the environment in order to maximize rewards and […]... Read more
NEW! Publication on Difference between forensic patients with schizophrenia spectrum disorders in Italy and other European countries
We are pleased to announce that an article by the EU-VIORMED group has been published in Crimal Behaviour and Mental Health (Impact Factor: 1.1) on Aug, 2023. There has been a substantial change in the law on the provision of secure health services for offender-patients in Italy, a country currently with the lowest general psychiatry […]... Read more
NEW! Publication on Exposure to violence in childhood and risk of violence in adult schizophrenia
We are pleased to announce that an article by the EU-VIORMED group has been published in Schizophrenia Bulletin Open (Impact Factor: 5.3) on Aug, 2023. Consent to treatment is a cornerstone of medical ethics and law. Nevertheless, very little empirical evidence is available to inform clinicians and policymakers regarding the capacities of forensic patients with […]... Read more
NEW! Publication on treatment Decision-Making Capacity in Forensic vs Non-forensic Psychiatric Patients
We are pleased to announce that an article by the EU-VIORMED group has been published in Schizophrenia Bulletin Open (Impact Factor: 5.3) on June 16, 2022. Consent to treatment is a cornerstone of medical ethics and law. Nevertheless, very little empirical evidence is available to inform clinicians and policymakers regarding the capacities of forensic patients […]... Read more
NEW! Publication on decision-making and risk-taking in forensic and non-forensic patients with schizophrenia spectrum disorders
We are pleased to announce that an article by the EU-VIORMED group has been published in Schizophrenia Research: Cognition (Impact Factor: 2.3) on May 19, 2022. Studies of patients with schizophrenia and offenders with severe mental disorders decision-making performance have produced mixed findings. In addition, most earlier studies have assessed decision-making skills in offenders or […]... Read more
NEW! Publication on neurocognition and social cognition in patients with schizophrenia spectrum disorders with and without a history of violence
We are pleased to announce that an article by the EU-VIORMED group has been published in Translational Psychiatry (2021 Impact Factor: 6.3) on Dec 8, 2021. Neurocognitive impairment has been extensively studied in people with schizophrenia spectrum disorders and seems to be one of the major determinants of functional outcome in this clinical population. Data […]... Read more